| Seroprevalence and risk factors associated with bovine brucellosis in the Potohar Plateau, Pakistan S Ali, S Akhter, H Neubauer, F Melzer, I Khan, EN Abatih, H El-Adawy, ... BMC Research Notes 10, 1-11, 2017 | 74 | 2017 |
| Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes S Gulluoglu, EC Tuysuz, M Sahin, A Kuskucu, CK Yaltirik, U Ture, ... Brain research 1700, 199-210, 2018 | 32 | 2018 |
| Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide S Turk, C Turk, MW Akbar, B Kucukkaraduman, M Isbilen, ... Plos one 15 (11), e0242497, 2020 | 25 | 2020 |
| A stemness and EMT based gene expression signature identifies phenotypic plasticity and is a predictive but not prognostic biomarker for breast cancer MW Akbar, M Isbilen, N Belder, SD Canli, B Kucukkaraduman, C Turk, ... Journal of Cancer 11 (4), 949, 2020 | 14 | 2020 |
| A novel 20-gene prognostic score in pancreatic adenocarcinoma S Demirkol Canlı, E Dedeoğlu, MW Akbar, B Küçükkaraduman, M İşbilen, ... PloS one 15 (4), e0231835, 2020 | 10 | 2020 |
| Phenotype-based variation as a biomarker of sensitivity to molecularly targeted therapy in melanoma KM Senses, M Ghasemi, MW Akbar, M Isbilen, AL Fallacara, ... Medchemcomm 8 (1), 88-95, 2017 | 8 | 2017 |
| Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis M Mooring, GA Yeung, P Luukkonen, S Liu, MW Akbar, GJ Zhang, ... Science Translational Medicine 15 (715), eade3157, 2023 | 7 | 2023 |
| Predictive Gene Signature for Pyrazolopyrimidine Derivative c-Src Inhibitor 10a Sensitivity in Melanoma Cells B Kucukkaraduman, C Turk, AL Fallacara, M Isbilen, KM Senses, ... ACS Medicinal Chemistry Letters 11 (5), 928-932, 2020 | 4 | 2020 |
| Epithelial-to-Mesenchymal Transition Is Not a Major Modulating Factor in the Cytotoxic Response to Natural Products in Cancer Cell Lines B Kucukkaraduman, EG Cicek, MW Akbar, S Demirkol Canli, B Vural, ... Molecules 26 (19), 5858, 2021 | 2 | 2021 |
| Plasticity as an Underlying Mechanism of Tumor Heterogeneity in Breast Cancer MW Akbar, M Isbilen, B Kucukkaraduman, SD Canli, E Dedeoglu, ... bioRxiv, 2020.03. 11.987511, 2020 | 2 | 2020 |
| Characterization of chemosensitivity profiles of breast cancer cell lınes, with and without stem cell like features MW Akbar PQDT-Global, 2014 | 2 | 2014 |
| UYGULAMAYA YÖNELİK GENETİK BİLİMCİ GÖZÜ İLE KANSERDE GELECEK ÖNGÖRÜLERİ AO Güre, S Demirkol, MW Akbar, AG Akçay | 1 | |
| Breast Cancer Plasticity after Chemotherapy Highlights the Need for Re-Evaluation of Subtyping in Residual Cancer and Metastatic Tissues IB Padzińska-Pruszyńska, MW Akbar, M Isbilen, E Górka, ... International Journal of Molecular Sciences 25 (11), 6054, 2024 | | 2024 |
| Targeting breast cancer stem cells MW Akbar, M Isbilen, N Belder, S Demirkol, B Kucukkaraduman, O Sahin, ... FEBS OPEN BIO 9, 320-321, 2019 | | 2019 |
| Determination of drug sensitivity subgroups in acute myeloblastic leukemia by the detection of gene-based cancer biomarkers and the prediction of prognosis and treatment S Turk, M Ghasemi, M Akbar, M Okay, A Erikci, N Sayinalp, ... FEBS OPEN BIO 9, 2019 | | 2019 |
| Uygulamaya Yönelik Genetik Bilimci Gözüyle Kanserde Gelecek Öngörüleri S DEMİRKOL CANLI, A Güre, A Akçay, M Akbar Kısayol Yayınları, 2018 | | 2018 |
